Cardiac Fibrosis is the abnormal buildup of fibrous connective tissue within the heart, most often in the myocardium (heart muscle). In plain terms, it is “scarring” or “stiffening” of heart tissue that can disrupt pumping and electrical conduction. It is a pathologic process discussed across cardiology, heart failure medicine, electrophysiology, and cardiac imaging. It is commonly referenced when interpreting echocardiography and cardiac magnetic resonance (CMR) findings, and when assessing prognosis.

Interventricular Septum Defect is a defect (opening) in the wall between the left and right ventricles. It is most commonly discussed in the domain of congenital heart disease, but it can also be acquired after myocardial infarction (heart attack). Clinically, it is evaluated as a cause of a cardiac murmur, abnormal intracardiac blood flow (shunt), and heart failure physiology. It is commonly identified and characterized using echocardiography and sometimes cardiac catheterization.

The Interatrial Septum is the wall of tissue that separates the right atrium from the left atrium. It is a core structure in cardiac anatomy and is closely tied to congenital heart disease and intracardiac blood flow patterns. Clinicians commonly assess it with echocardiography and cardiac imaging to evaluate shunts, embolic risk, and atrial structure. It is also a key landmark for procedures that require access to the left atrium.

Structural Heart Disease refers to abnormalities of the heart’s anatomy that affect how blood flows through the heart and great vessels. It is a clinical domain spanning diagnosis (imaging and hemodynamics) and treatment (medical therapy, catheter-based intervention, and surgery). The term is commonly used in cardiology, cardiothoracic surgery, echocardiography, and multidisciplinary “heart team” decision-making. It most often centers on cardiac valves, congenital defects, chambers, and adjacent structures such as the aorta.

A Cardiac Ward is a hospital inpatient unit dedicated to people with heart and vascular conditions. It is a care setting rather than a single test or procedure. It commonly supports acute care, monitoring, and treatment adjustment in cardiology. It is used in general hospitals and specialist cardiac centers, often alongside a coronary care unit (CCU) and cardiac catheterization services.

A Cardiac Clinic is a clinical service where patients are assessed and managed for heart and vascular conditions. It sits in the domain of cardiovascular diagnosis, risk stratification, and longitudinal therapy planning. It is commonly used in outpatient settings, but it can also support post-hospital follow-up and pre-procedure assessment. It often coordinates diagnostic testing, medications, lifestyle counseling, and referrals for procedures or surgery when needed.

A Cardiac Unit is a hospital-based clinical area dedicated to caring for patients with cardiovascular disease. It is part of acute care medicine and focuses on monitoring, diagnosis, and treatment of heart-related conditions. It is commonly used for patients needing close observation, continuous electrocardiogram (ECG) monitoring, and rapid intervention. Depending on the institution, it may function as a cardiology ward, a coronary care unit (CCU), or a cardiac intensive care unit (CICU).

Cardiac Telemetry is continuous electrocardiographic (ECG) monitoring performed at a distance. It is a diagnostic monitoring approach used in acute care cardiology and hospital medicine. It tracks heart rhythm and heart rate to detect clinically important changes over time. It is commonly used in emergency departments, telemetry wards, step-down units, and perioperative settings.

High Sensitivity Troponin is a blood test used to detect very small amounts of cardiac troponin released with myocardial (heart muscle) injury. It is a diagnostic test in cardiology and emergency medicine, most often used when evaluating chest pain and suspected acute coronary syndrome (ACS). It supports early diagnosis and risk stratification for myocardial infarction (MI), alongside the electrocardiogram (ECG) and clinical assessment. It can also be elevated in non-ischemic conditions, so results must be interpreted in context.

A Cardiac Biomarker Panel is a set of blood tests used to detect and monitor heart-related injury, stress, or inflammation. It is a diagnostic test in clinical cardiology and emergency medicine, not an anatomic structure or a procedure. It is commonly used in the evaluation of chest pain, suspected acute coronary syndrome (ACS), and acute dyspnea. Results are interpreted alongside the electrocardiogram (ECG), symptoms, and imaging such as echocardiography.